Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Diffusion Pharmaceuticals and WPD Pharmaceuticals get new chief medical officers.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.
New chief business officer named at Ovoca Bio, and a new chairman at Opthea Ltd.
A new CEO is appointed at AZTherapies, while directors are named at AstraZeneca, Pfenex, X4 Pharmaceuticals and Medicenna Therapeutics.
American Injectables gets a new CEO, while Hemostemix names a new chief medical officer.
The appointment of Belén Garijo as CEO of the German major from May next year is a small but significant step on the road to addressing gender inequality at the very top level of management in the world of big pharma.
New directors at 4D Pharma, Neurogene And Zogenix.
Plus promotions at Agios Pharmaceuticals, Bafna Pharmaceuticals, Miragen Therapeutics and Compass Therapeutics.
The former CEO of Cipla’s India business is set to steer JB Chemicals and Pharmaceuticals, as the Indian firm embarks on a new phase of growth, backed by a revamped board, following its takeover by US private equity firm KKR.
New CMOs appointed at Black Diamond Therapeutics and Dicerna Pharmaceuticals.
Two new independent directors are appointed at Bristol Myers Squibb and new CEOs are named for Immunicum, Race Oncology and Recce Pharmaceuticals.
New CEO named at Therapix Biosciences, and a new COO appointed at Elgia Therapeutics.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.